# Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

> **NCT01880983** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 150 (actual)

## Conditions studied

- Erythropoietic Protoporphyria (EPP)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01880983
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01880983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01880983, "Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01880983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*